Clarus Ventures

Clarus Ventures

A venture capital firm from Cambridge, Massachusetts (United States) focusing on healthcare businesses

Clarus Ventures is a venture capital firm from Cambridge, Massachusetts (United States) that focuses on businesses in the healthcare industry. Founded in 2005 by David Field, it funds private equity, early stage ventures and late stage ventures. Founded by a team of experienced professionals, it invests on life science industries such as in biopharmaceuticals and medical technology companies that are into research and development, commercialization, business development and operations management at the global level.

Clarus manages over $2.6 billion, and has put resources into more than 50 private and public businesses in the biotechnology, medical device and diagnostic areas. It utilizes a hands-on approach and use its logical and clinical advancement expertise to invest in new medicines that improve individuals' lives.

Timeline

2005

Founded

Funded Companies

Company
Description
Website
Industry
Location

A company focused on development of products to treat central nervous system disorders, pain and rare diseases

A company developing products to treat respiratory diseases, including chronic obstructive pulmonary disease

Gritstone Oncology is a Emeryville, California-based biotechnology company developing neoantigen-specific cancer immunotherapies.

Developing gene therapies to potentially cure rare diseases.

A biotechnology company developing diagnostic tools for cancer

A medical device company developing computer-assisted robotic system to harvest follicular units

A pharmaceutical company engaged in the discovery and development of medicines for inflammatory conditions

A company developing hand-held diagnostic and monitoring devices for screening and management medical conditions

A biopharmaceutical company that develops therapies for age-related macular degeneration and other opthalmic diseases

A company developing therapeutic proteins and monoclonal antibodies

A biotechnology company developing and commercializing therapeutics for the treatment of respiratory and allergic diseases

A company developing antigen for ophthalmology, dermatology and inflammatory diseases

A company developing surgical sealants

A pharmaceutical company focused on developing products for the treatment of glaucoma

A biopharmaceutical company that develops drugs for autoimmune and inflammatory diseases

Oxford Immunotec is a Marlborough, Massachusetts-based company.

A biotechnology company developing antibody fragment technology for opthalmic conditions

Cleave Biosciences is a Burlingame, California-based company.

SFJ Pharmaceuticals is a Pleasanton, California-based company.

21 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
880,000,000
789,700,000
May 17, 2017
40,000,000
40,000,000
September 18, 2014
880,000,000
789,700,000
May 17, 2017
100,000,000
100,000,000
August 5, 2014
880,000,000
789,700,000
May 17, 2017
880,000,000
789,700,000
May 17, 2017
8 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Ari Brettman

Principals/Advisor

Barry Gertz

Partners

Dennis Henner

Venture and Operating Partner

Edward Scolnick

Venture and Operating Partner

Emmett Cunningham

Managing Director

Ian Clark

Venture and Operating Partner

Kiran Reddy

Venture and Operating Partner

Kurt C. Wheeler

Managing Director

Lazar Dimitrov

Principals/Advisor

Nicholas Galakatos

Managing Director

Nicholas J. Simon

Managing Director

Paris Panayiotopoulos

Venture and Operating Partner

Robert DeBenedetto

Venture and Operating Partner

Robert W. Liptak

Managing Director

Scott Requadt

Venture and Operating Partner

William Young

Venture and Operating Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Annexon Biosciences

Avrobio

Avrobio

Cleave Therapeutics

Flowonix

Forty Seven

Galera Therapeutics

GrayBug

Gritstone Oncology

PATH

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.